ArticleTranslational oncology2022

A novel treatment strategy of HER2-targeted therapy in combination with Everolimus for HR+/HER2- advanced breast cancer patients with HER2 mutations.

Jing Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.